UGT2B17 inactivates the signaling lipid prostaglandin E2 by conjugation to glucuronic acid and downregulates the prostaglandin signaling pathway, which displays tumor suppressor functions in B-cells [6]. The gene discussed is UGT2B17; the disease is neoplasm.